Stan Zygmunt joins Bo for a fascinating conversation on quantum physics, material science, scientific discovery, and why reality gets increasingly strange the deeper we look. An MIT-trained physicist and longtime Valparaiso University professor, Stan has spent nearly four decades teaching, researching, and using computational physics to understand everything from catalysts and electronic materials to the atmospheres surrounding distant stars.

Victoria Pelletier joins Bo for a conversation about leadership, scaling businesses, hiring great people, and staying valuable as AI transforms the workplace. A corporate executive, professional speaker, author, and board director, Victoria has spent her career leading large-scale business and technology transformations while helping organizations navigate leadership, culture, and workforce change.

Eric Robinson joins Bo for a fascinating conversation about one of the most unusual career paths imaginable—going from Baptist pastor to spending 24 years as an FBI Special Agent. During his career, Eric investigated drug cartels, gangs, organized crime, terrorism, financial crimes, crimes against children, public corruption, and national security matters, while also serving 15 years as a SWAT operator and roughly a decade as a firearms and tactical instructor.

Adam Goldman joins Bo for a practical conversation on franchising, business ownership, and how entrepreneurs can use proven systems to build a business without starting completely from scratch. With 18 years in the franchise industry and experience as a former franchisee himself, Adam now works as a franchise coach and consultant, matching entrepreneurs with opportunities across 75 different industries.

Jerry Brazie joins Bo for an unforgettable conversation about resilience, entrepreneurship, and building success from almost nothing. After growing up as one of nine children in extreme poverty, stealing food to survive, dropping out of high school, losing vision in one eye, and surviving being stabbed, Jerry went on to build, buy, and sell businesses that have generated more than $450 million in revenue.

Tom Hruby, ex-Navy SEAL, entrepreneur, author, and former Division I football player, joins Bo for a conversation about discipline, purpose, leadership, and building a meaningful life after the military. Tom shares his journey from working construction in Northwest Indiana to pursuing the SEAL teams after 9/11, surviving the grueling BUD/S pipeline, deploying to Afghanistan and Iraq, and eventually accomplishing another unlikely goal—playing Big Ten football at Northwestern in his 30s.

Joris Teelenboom, CEO and co-founder of Fairmint, joins Bo for a deep conversation on how blockchain, programmable equity, and AI are changing the way private companies raise capital, manage ownership, and create liquidity. Joris explains why traditional equity infrastructure is still built on outdated systems and how Fairmint is creating modern rails that allow founders, investors, and employees to manage shares faster, cheaper, and with greater transparency.

Kenny “Red Ninja” joins Bo for a wide-ranging conversation about the realities of modern law enforcement, criminal interdiction, organized crime, and what actually happens on America’s highways. A 19-year Indiana police veteran, Kenny specializes in intercepting contraband while it is in transit and now travels the country training other officers in criminal interdiction.

Melissa Smith, organizational performance expert and author of The Capable and Checked Out, joins Bo for a conversation on why bright, capable kids can struggle with initiative, resilience, ownership, and internal motivation. Drawing from her career in organizational performance, leadership systems, and M&A, Melissa explains how the same environmental forces that influence performance in the workplace also shape motivation and behavior at home.

Dr. Ian Justl Ellis, physician and founder of VoFit, joins Bo to break down GLP-1 weight-loss medications, why patients can experience significant side effects, and how he approaches precision dosing. Dr. Ellis explains that because these medications have long half-lives, drug levels can continue accumulating even when the weekly dose stays the same—potentially pushing a patient beyond what he calls their therapeutic “sweet spot.”